Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
The epidemiology of inflammatory bowel disease
Johan Burisch,
Pia Munkholm
Department of Clinical Medicine
178
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The epidemiology of inflammatory bowel disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Inflammatory Bowel Disease
100%
Crohn's Disease
66%
Ulcerative Colitis
66%
Postoperative Complications
33%
Epidemiological Data
33%
Disease Course
33%
Mortality Risk
33%
Age at Diagnosis
16%
Risk of Malignancy
16%
Disease-specific
16%
Lymphoproliferative Disorders
16%
Colorectal Cancer
16%
Community Setting
16%
Patient Empowerment
16%
EHealth Strategy
16%
Cancer Risk
16%
Disease-specific Mortality
16%
Population-based Cohort Study
16%
Primary Sclerosing Cholangitis
16%
Colorectal Cancer Risk
16%
Surgical Complications
16%
Intestinal Cancer
16%
Persistent Inflammation
16%
Background Population
16%
Europe
16%
Extraintestinal Cancer
16%
Unknown Etiology
16%
Disease Prognosis
16%
Medical Therapy
16%
Long-standing Disease
16%
Family History of Colorectal Cancer
16%
Intrahepatic Cholangiocarcinoma (iCCA)
16%
Specific-causes of Death
16%
Small Bowel Cancer
16%
Disease Pattern
16%
Faroe Islands
16%
AIMS™
16%
Young Age
16%
Crohn's Colitis
16%
Self-management
16%
Extensive Disease
16%
Surgery Rates
16%
Malnutrition
16%
High Incidence
16%
Patient Mortality
16%
Medicine and Dentistry
Cohort Effect
100%
Inflammatory Bowel Disease
100%
Diseases
83%
Ulcerative Colitis
83%
Crohn's Disease
83%
Colorectal Carcinoma
50%
Postoperative Complication
50%
Intestine Cancer
50%
Disease Course
33%
Cholangiocarcinoma
33%
Patient with Inflammatory Bowel Disease
16%
Cancer Risk
16%
Primary Sclerosing Cholangitis
16%
e-Health
16%
Cancer
16%
Family History
16%
Cohort Analysis
16%
Lymphoproliferative Disease
16%
Combination Therapy
16%
Disease
16%